| The past year has been an exciting and eventful one for VPHi. It marked the successful completion of several EU-funded projects, resulting in the release of key documents, impactful content, and memorable events. To celebrate these milestones, we have compiled all the highlights in our annual report. Dive in and relive an incredible year and make sure you collect all the tools and resources we have prepared for you to use in your daily research activities. |
| | |
On 6 Jan 2024, the FDA released a new draft guidance. Comments on the draft are due by 7 April 2025. This draft takes into consideration the more than 800 comments that FDA received in response to their two discussion papers that were published in 2023.
|
|
On 16 Jan 2025 the European Data Protection Board published its Guidelines 01/2025 on pseudonymisation, marking the first comprehensive guidance on this data protection measure since the implementation of GDPR.
|
|
TEHDAS2, a European Joint Action, is developing guidelines and technical specifications to enable seamless use of health data across Europe under the upcoming European Health Data Space (EHDS). Have your say until the 28th of February! |
|
| |
Explore the fascinating journey of diabetes care, from ancient discoveries to life-saving insulin and AI-driven closed-loop systems. Learn how computer models now personalise treatments, transforming lives and shaping a hopeful future for a cure.
|
|
At VPH Institute, we’re thrilled to share a remarkable milestone in our journey of advancing biomedical innovation. The European Commission’s Innovation Radar has officially recognized our organization as a Key Innovator for our contributions to the SIMCor project. |
|
The first character of the year is our Executive Director, Lies Geris, who was recently awarded with the honorary doctorate degree by the University of Amsterdam. Ad majora! |
|
This info kit aims to provide an essential information package for the research community to engage with key stakeholders in the realm of in silico medicine, making available clear instructions, guidelines, and ready to use resources to navigate the complexities of stakeholder engagement effectively.
|
|
We are happy to announce VPHi's key role in dealii-X. With its objectives to revolutionise personalised medicine through exascale computing, this initiative promises to break new ground in the field of digital twin and high-performance computing (HPC).
|
|
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
|
|
| YOUNG SCIENTISTS COMMITTEE |
| | |
Did you graduate in 2024 with a thesis in in silico medicine? Submit your thesis by 28 Feb 2025!
|
|
|
|
New calls with deadlines in February Check them out!
|
|
|
|
| | SAVE THE DATE!
1 - 4 Sept 2026, Milan - Italy |
|
7 Feb 2025, Online Registration open
|
|
15-17 Apr 2025, Leuven - Belgium Submission extended! 14 Feb 2025
|
|
15-18 Apr 2025, Leuven - Belgium Breakout & Tutorial submission deadline: 16 Feb 2025
|
|
1-5 Jun 2025, Dallas, TX - USA Submission extended! 4 Feb 2025
|
|
2-4 Jun 2025, Manchester - UK Abstract submission deadline: 28 Feb 2025
|
|
11-13 Jun 2025, Milan - Italy Registration open
|
|
7-9 Jul 2025, Singapore Submission deadline: 31 Jan 2025
|
|
3-5 Sept 2025, Barcelona - Spain Abstracts submission deadline: 31 Mar 2025 |
|
8-10 Sept 2025, Leuven - Belgium Application deadline: 31 Mar 2025
|
|
|
| |
ARE YOU NOT A VPHi MEMBER YET? Join us |
| "The Virtual Physiological Human will revolutionise the way health knowledge is produced stored and managed as well as the way in which healthcare is currently delivered." European Commission |
| |
|
|
